PREPULSID TAB 5MG DIN 00836311
Status: Cancelled Post Market
Holder: JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC.
Molecule: CISAPRIDE (CISAPRIDE MONOHYDRATE)
Health Canada record
| Active ingredient(s) | CISAPRIDE (CISAPRIDE MONOHYDRATE) 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A03FA02 CISAPRIDE |
| Original market date | 31-Dec-1990 |
| Current status date | 25-Aug-2000 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Pharmaceutica — licence , not currently licensed, last inspection rating C (2025-05-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CISAPRIDE (CISAPRIDE MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00836354 | PREPULSID SUS 1MG/ML | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Suspension | CISAPRIDE (CISAPRIDE MONOHYDRATE) 1 MG | Cancelled Post Market |
| 00836338 | PREPULSID TAB 10MG | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Tablet | CISAPRIDE (CISAPRIDE MONOHYDRATE) 10 MG | Cancelled Post Market |
| 02054817 | PREPULSID TAB 20MG | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | Tablet | CISAPRIDE (CISAPRIDE MONOHYDRATE) 20 MG | Cancelled Post Market |